Michael Bookman insider trades

Open-market stock purchases and sales by Michael Bookman, CHIEF LEGAL OFFICER, SECRETARY at Immuneering Corp, from SEC Form 4 filings since Apr 20, 2021.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -35%.

Recent trades

DateStockTradeValue
Feb 3, 2026IMRX Immuneering CorpBought (not open market)—

Companies traded

  • IMRX Immuneering Corp: 3 buys, last Feb 3, 2026
  • FREQ Frequency Therapeutics, Inc: other filings, last Apr 20, 2021

Get free alerts when Michael Bookman files a new trade →